Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
AHA Journals This Week | July 6, 2020
07/06/2020 | AHA Journals This Week July 6, 2020
Circulation Research: Compendium on Atrial Fibrillation
06/23/2020 | CIRCULATION RESEARCH, Compendium, Atrial Fibrillation, and CVD
CIRCULATION Editor's Picks | May/June 2020
06/17/2020 | CIRCULATON Editor's Picks for April/May 2020
Cardiovascular Disease in American Indians and Alaskan Natives
05/28/2020 | The prevalence of cardiovascular disease (CVD) has been rising in American Indians and Alaskan Natives; CVD is the leading cause of death in those population groups over the past 50 years.
Collaboration with LLNL shares COVID-19 research data
05/22/2020 | The American Heart Association is pleased to announced that our collaboration with Lawrence Livermore National Labs (LLNL) on the protein atlas developed through the AHA Center for Accelerated Discovery is being leveraged to help accelerate discovery of therapeutic antibodies or antiviral drugs for SARS-CoV-2, the virus that causes COVID-19.
QCOR 2020 Science News
05/15/2020 | Science News from Quality of Care and Outcomes Research (QCOR) 2020 Scientific Sessions | May, 15-16 2020 | Reston, VA
Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients
05/07/2020 | Acute venous thromboembolism (VTE), comprising deep venous thrombosis (DVT) of the legs or pelvis and pulmonary embolism (PE), is a frequent, costly complication in hospitalized patients.